[Breaking News] Priority Vaccination for Ages 18-49 to Begin from the 17th of Next Month
2 Million People Selected by Local Governments for 'Priority Vaccination'
Pre-Reservation from August 3 to 6... Vaccination from August 17 to September 11
![[Breaking News] Priority Vaccination for Ages 18-49 to Begin from the 17th of Next Month](http://www.asiae.co.kr/news/img_view.htm?img=2021073012380557289_1627616285.jpg)
[Asia Economy Reporter Lee Chun-hee] The COVID-19 Vaccination Response Promotion Team announced the 'COVID-19 Vaccination Implementation Plan for August to September' on the 30th.
According to this plan, the general public aged 18 to 49 will receive the Pfizer or Moderna mRNA (messenger ribonucleic acid) vaccine from the 26th of next month until September 30. Pre-registration for these individuals will be conducted from the 9th to the 18th of next month.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Trump Puts Iran Strike on Hold One Day Before Attack... "Full-Scale Offensive If Talks Fail"
- At 24°C It's Iced Coffee, at 31°C Tube Ice Cream... "It's Only May" But Convenience Stores Already Know: The 'Summer Boom' Thermometer
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
However, for about 2 million people deemed to require priority vaccination based on the characteristics and quarantine situations of each local government, pre-registration will be held from the 3rd to the 6th of next month, with vaccinations taking place from August 17 to September 11.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
